Metarhodopsin-II is the light-excited form of rhodopsin that triggers G protein function. Metarhodopsin-II is stabilized when the N-terminus of the carboxyl (340-350) tail peptide of the -subunit of transducin (Gt ) is crosslinked to rhodopsin cysteine 140 or the 340-350 peptide C-terminus of Gt is crosslinked to rhodopsin cysteine 316. When the N-terminus of the peptide is coupled to C316 the MI M MII equilibrium is not aVected. The evidence suggests that the N-terminus of the 340-350 region of Gt is located near C140 when transducin stabilizes metarhodopsin-II and alternative explanations are suggested for the eVectiveness of the 340-350 Gt tail peptide when bound to C316.
Introduction
The G protein coupled receptor (GPCR) superfamily constitutes more that 1% of the human gene complement and controls a very wide range of physiological processes (Fredriksson, Lagerstrom, Lundin, & Schioth, 2003; KleinSeetharaman, 2002) . Rhodopsin is the best understood GPCR and is the photoreceptor protein in the rod cells of the retina, where it functions as a single photon detector for dim light vision. Rhodopsin is a prototypical GPCR, being the only GPCR for which high-resolution crystal structures are available (Imamoto, Kataoka, Tokunaga, & Palczewski, 2000; Li, Edwards, Burghammer, Villa, & Schertler, 2004; Okada et al., 2004; Palczewski et al., 2000; Teller, Okada, Behnke, Palczewski, & Stenkamp, 2001) .
Rhodopsin is activated by the absorption of a photon by the covalently coupled 11-cis retinal chromophore, which causes isomerization of the retinal. Photoactivation of rhodopsin leads to the formation of a series of short-lived photo-intermediates that culminate in an equilibrium between metarhodopsin I (MI, with peak absorbance near 480 nm) and metarhodopsin II (MII, with peak absorbance near 380 nm), that is established in milliseconds at physiological temperatures. A model for the membrane surface features of metarhodopsin I, that is the direct precursor to metarhodopsin II, has recently been proposed based on X-ray diVraction analysis of an epitope peptide complex with an antibody that stabilizes metarhodopsin I (Piscitelli et al., 2006) .
Metarhodopsin II is the conformation of the receptor that binds to and excites G proteins, but little is known about the detailed molecular structure of metarhodopsin II. Spin-spin interactions in electron spin resonance have shown that the transmembrane helical bundle expands at the cytoplasmic face of rhodopsin upon formation of metarhodopsin-II and that the largest movement is helix VI moving away from the core of the helical bundle (Hubbell, Altenbach, Hubbell, & Khorana, 2003) . The binding of the G protein transducin stabilizes metarhodopsin II and leads to the release of GDP and the binding of GTP to activate transducin. The molecular mechanism of coupling of GPCRs and G proteins is a major unsolved problem in cellular signaling, which if it were better understood is expected to have many important implications for pharmacology.
The Gt C-terminal tail (340-350) has been found to be an important contact site for transducin binding to activated metarhodopsin-II (Aris et al., 2001; Hamm et al., 1988; Pulvermuller, Schroder, Fischer, & Hofmann, 2000) . Binding of the Gt C-terminal tail peptide,
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, shifts the MI M MII equilibrium to stabilize MII and the amino acid sequence of the C-terminal tail of the -subunits of G proteins are thought to determine receptor coupling speciWcity (Wess, 1998) . Photocrosslinking, diVerential chemical modiWcation, and mutagenesis studies all indicate that the cytoplasmic C IV surface loop (including residues in helix 8) of rhodopsin is part of the Gt C-terminal peptide binding site (Acharya, Saad, & Karnik, 1997; Cai, Itoh, & Khorana, 2001; Wang, Kim, Ablonczy, Crouch, & Knapp, 2004) . Fluorescence quenching studies place the amino terminus of Gt C-terminal peptide analogs near C140 during metarhodopsin-II stabilization (Janz & Farrens, 2004) . Mutagenesis studies suggest that a hydrophobic region on the C III surface loop of rhodopsin mediates Gt C-terminal peptide analogreceptor interactions (Yang, Farrens, Hubbell, & Khorana, 1996) .
In the present study, we found that analogs of the C-terminal tail of Gt can stabilize MII when they are covalently bound to one of the two native reactive cysteines, C140 and C316 on the cytoplasmic face of rhodopsin, if they are bound with a speciWc N M C polarity. Of the two reactive cysteines in dark-adapted rhodopsin, C316 is most reactive. C316 will react with -haloacetyl compounds readily, while under the same conditions C140 shows little to no reactivity (De Grip, Bonting, & Daemen, 1975; McDowell, Mas, GriYth, & Hargrave, 1979; Sale, Towner, & Akhtar, 1977) . N-maleimide derivatives have been shown to modify both C140 and C316 in dark-adapted rhodopsin and 316 can be blocked before the maleimide coupling (McDowell et al., 1979; Mielke, Alexiev, Glasel, Otto, & Heyn, 2002; Sale et al., 1977) . We used synthetic peptides that diVer in placement of a chemical crosslinking group, either at the N-terminus or the C-terminus of the Gt 340-350 peptide analogs to establish the N ! C orientation of the covalent binding of the reactive peptide relative to C140 or C316 on rhodopsin. By selectively crosslinking the Gt C-terminal tail peptide to either C140 or C316 on rhodopsin and measuring stabilization of metarhodopsin-II by the crosslinked peptides, we assessed the orientations of the peptides on the rhodopsin surface that are able to stabilize metarhodopsin-II. This information provides evidence on the nature of productive transducin-metarhodopsin-II interactions and provides a foundation for experiments that can provide more detailed information on the amino acid residues of the light-activated rhodopsin that are critical for interacting with Gt and for triggering GTP/GDP nucleotide exchange.
Materials and methods
Rod outer segment preparation
Bovine retinas were obtained from Schenk Packing Co. (Stanwood, WA). Manipulations of retinas, rod outer segments (ROS), and rhodopsin were carried out under dim red light, unless otherwise indicated. Retinas were suspended in ice-cold buVer A (0.05 M monobasic potassium phosphate, 0.015 M dibasic potassium phosphate, 1 mM Mg(OAc) 2 , 1 mM DTT, 0.1 mM EDTA, pH 7.0, sparged with argon). ROS were sheared from the retinas by mechanical shaking (Stone, Farnsworth, & Dratz, 1979) , puriWed with discontinuous sucrose gradients (27.0%, 28.7%, 34.0%, and 38.0%), stored in liquid nitrogen. The purity of the rod outer segments was determined by measuring the ratio of total protein absorbing at 280 nm to photoactivatable rhodopsin at 500 nm. Rhodopsin concentrations were calculated from the diVerence spectrum (unbleached-bleached) at 500 nm ( 500) in the presence of 3% lauryldimethylamineoxide (LDAO), using a molar extinction coeYcient of 40,600 M ¡1 cm
¡1
. A typical OD 280 / 500 ratio for the rod outer segments was approximately 2.
Peptide synthesis
Synthetic peptides were prepared using a Rainin Protein Technologies PS3 peptide synthesizer and standard Fmoc chemistry. The amino acid analog, Fmoc diamino propionic acid (Dpr) (Advanced Chem Tech) was immobilized on PAC resin (Perceptive Biosystems) in a separate reaction, as recommended by the resin supplier. Iodoacetate was added to both reactive amine of peptide VLEDLRD(Abu)GL(Dpr) using SIA (N-succinimidyl iodoacetate) (Pierce) following the manufacturer's directions. Biotinyl-succinimidyl ester (B-SE) (Molecular Probes) was added to the N-terminus of peptide VLEDLRD(Abu)GL(Dpr), while the peptide was on the wang resin. After the biotinylated peptide was cleaved from the resin (in 95% TFA, 3% water, and 2% thioanisole), iodoacetate succinimidyl ester (S-IA) was added to the free amine on the side chain of Dpr to yield the Wnal product, biotin-VLEDLRD(Abu)GL(Dpr)-IA (B23S-IA). Maleimide succinimidyl ester (SMCC) was added to the amino termini of the peptide VLEDLRD(Abu)GL(Dpr) while it was immobilized on Wang resin. Peptide Maleimide-VLEDLRD(Abu)GL(Dpr) (M23S) was cleaved form the resin (in 95% TFA, 3% water, and 2% thioanisole). All synthetic peptides were puriWed by RP-HPLC. PuriWed peptide masses and sequences were conWrmed by MALDI-TOF mass spectrometry (Bruker BiXex III) and LC MS/MS mass spectrometry (Agilent XCT Ultra). Stock solutions of the peptides were prepared by dissolving the peptide in buVer B (50 mM Hepes, 100 mM NaCl, and 1 mM MgCl 2 ) at pH 8, immediately prior to use.
Chemical coupling of peptides to rhodopsin
Two reactive cysteines C140 and C316 are solvent-exposed on the cytoplasmic surface of rhodopsin in intact disk membranes. Peptides were crosslinked selectively to C140 or C316 on rhodopsin in rod outer segment membranes after the plasma membranes were disrupted by exposure to low salt conditions. To selectively couple peptide to C140, C316 was blocked by Wrst reacting it with 4,4Ј-dithiodipyridine (DTP) (Albert et al., 1997; Chen & Hubbell, 1978; De Grip et al., 1975; De Grip & Daemen, 1982; de Grip, van de Laar, Daemen, & Bonting, 1973; McDowell et al., 1979; Mielke et al., 2002; Regan, de Grip, Daemen, & Bonting, 1978) . Rod outer segment stock solutions were pelleted and resuspended in 10 mM Tris pH 7.2, to break plasma membranes by osmotic shock and dissociate disk membranes in the low salt, and adjusted to a Wnal concentration of 20 M rhodopsin. A fourfold molar excess of DTP was added to the rhodopsin sample being stirred in a temperature controlled cuvette holder (Quantum Northwest). The thiopyridone reaction product was monitored at 30 s intervals in a Cary-50 UV-vis spectrophotometer ( max 323 nm, 7800). Following blocking of »1 cysteine per rhodopsin, the ROS membranes were washed 3£ by centrifugation to remove unreacted DTP. Peptide IA-VLEDLRD(Abu)GL(Dpr) or Biotin-VLEDLRD(Abu)GL (Dpr)-IA were added in a 30-fold molar excess and allowed to couple to rhodopsin overnight at 4°C. Excess peptide was removed from the samples by centrifugation, followed by resuspension in buVer B at pH 8 prior to spectroscopic analysis.
Light titration experiments
Rhodopsin rod outer segment membranes that were used in light titration experiments were suspended in buVer B and the Wnal pH adjusted to pH 8.0. For each light titration experiment, an aliquot of rhodopsin was bleached with a series of millisecond Xashes with orange light from a xenon Xash lamp Wltered through an OG515 long pass Wlter at 50-s intervals, and absorbance changes were measured during each interval. Each Xash bleached »8% of the rhodopsin. The appearance of metarhodopsin-II was detected by monitoring the diVerence in absorbance between 390 and 417 nm (390-417) (Parkes, Gibson, & Liebman, 1999) , using an Olis/ Shimadzu UV-3000 dual wavelength spectrophotometer, equipped with a temperature controlled cuvette holder. All light titration experiments were performed at 4°C and the sample compartment was purged with dry nitrogen gas.
DiVerence absorbance spectra
Absorbance spectra of rhodopsin in native membrane suspensions with and without peptide crosslinking were measured in a Cary 50 spectrophotometer with a temperature controlled sample holder and a special detector assembly that was mounted directly behind the cuvette in the sample compartment, to capture a large fraction of the light scattered by the turbid samples. Rhodopsin samples were placed in the temperature controlled sample holder and the temperature was allowed to equilibrate at 1°C at pH 8.0 while purging the sample compartment with dry nitrogen. Spectra of unactivated rhodopsin were measured and then samples were illuminated with >500 nm light from a Fiber Photics Illuminator 150 for 10 s, using an OG515 long pass Wlter and fully bleached absorbance spectra were acquired. The pH of the samples was measured following recording of spectra.
Mass spectrometry
The presence of chemically crosslinked peptides linked to rhodopsin was conWrmed by mass spectrometry. Chemical crosslinking to intact rhodopsin was detected by MALDI-TOF mass spectrometry of intact rhodopsin (Schey, Papac, Knapp, & Crouch, 1992) . Following chemical crosslinking an aliquot of rhodopsin-containing membranes was pelleted and resuspended in neat formic acid, diluted 10-fold in 50% acetonitrile, spotted on a MALDI target, mixed with 2,5-dihydroxybenzoic acid matrix (Bruker Daltonics) mass spectra were measured in linear mode. Following chemical crosslinking of peptides to C316 (5 M rhodopsin and 5 M peptide in 20 mM Hepes, 150 mM NaCl, pH 7.5, stirred on ice for 1 h in the light), the rhodopsin was chemically cleaved with CNBr and analyzed by MALDI-TOF mass spectrometry (Kraft, Mills, & Dratz, 2001 ). The rhodopsin was solubilized in 1% LDAO and reduced and alkylated by incubation with 20 mM DTT for 1 h at room temperature followed by a 1-h incubation with 100 mM iodoacetamide. Following reduction and alkylation the samples were cleaved with CNBr by Wrst precipitating with TCA to remove lipids and then resuspending and washing in ethanol 3£ to remove excess reagents. Rhodopsin samples were then dissolved in a minimum of neat triXuoroacetic acid and cleaved with the addition of 500£ molar excess CNBr in 70% triXuoroacetic acid. The cleavage reaction was terminated by diluting 10£ with water, freezing and lyophilizing to dryness. Samples were resuspended in water and lyophilized to dryness three times to remove excess triXuoroacetic acid and cyanogen bromide. Biotinylated peptides were enriched after washing oV free peptide and cleavage following the method of Girault et al., using magnetic streptavidin beads (Dynabeads M-280) prior to MADLI-TOF mass spectrometric analysis (Girault, Chassaing, Blais, Brunot, & Bolbach, 1996) . A dilution series of the digest to be analyzed was made in 20/80 water/acetonitrile before mixing 1:1 to 3:1 with saturated MALDI matrix in 20/80 water/acetonitrile ( -cyano-4-hydroxycinnamic acid). Typically, 0.1-0.3 L of matrix/sample mixture was spotted per well.
Results
The C-terminal 11 residues (340-350) of the -subunit of transducin are capable of shifting the MI M MII equilibrium by binding to and stabilizing MII (Hamm et al., 1988) . We synthesized a panel of Gt C-terminal tail peptide analogs containing thiol reactive groups, shown in Table 1 , and assessed their capacity to shift the MI M MII equilibrium. The amino acid residues on rhodopsin that have been reported to interact with peptide analogues of the C-terminal region of the transducin alpha subunit are colored green in Fig. 1 and rendered as sticks on the cytoplasmic face of the dark-adapted rhodopsin crystal structure. The reactive native cysteines 140 and 316 are rendered as yellow colored space Wlling models. Peptide IA-23S-IA (Table 1) with thiol-reactive iodoacetate groups on both the N-and C-termini was chemically crosslinked to C316 under conditions where C140 does not react with iodoacetate derivatives. The covalent addition of crosslinked peptide to intact rhodopsin was detected by MALDI-TOF mass spectrometry in the linear mode, as shown in Fig. 2 . The MALDI spectrum of the intact rhodopsin is rather broad due to heterogeneous glycosylation and the inherent low resolution of linear MALDI-TOF spectra of large proteins. The mass shift of the MALDI signal of the crosslinked rhodopsin (Fig. 2, blue trace) indicates that there was little or no unmodiWed rhodopsin remaining after peptide crosslinking and that there is approximately one peptide coupled per rhodopsin molecule under these conditions. The somewhat broader, asymmetric MALDI signal of the crosslinked sample may reXect the high laser power needed to obtain spectra of the complex, although a small portion of the rhodopsin might have more than one peptide crosslinked per rhodopsin molecule, contributing to the asymmetric tail on the high mass side of the MALDI spectrum.
We found that chemical coupling of the bifunctional peptide IA-23S-IA to cysteine 316 in non-activated rhodopsin, followed by photoactivation, led to a shift in the MI M MII equilibrium toward MII, as shown in Fig. 3A (red circles). Prior to removal of excess uncrosslinked peptide a maximal amount of metarhodopsin-II was stabilized (blue triangles), and the amplitude of this response is very similar to the maximum amount of metarhodopsin-II stabilization that can be obtained by fully functional, Table 1 Gt C-terminal peptide analogs IA, iodoacetyl; Abu, amino butyric acid; Dpr, , ,-diamino propionic acid.
Peptide amino acid sequence Peptide name
high-aYnity Gt C-terminal peptides or the intact heterotrimeric G proteins (Aris et al., 2001; Martin, Rens-Domiano, Schatz, & Hamm, 1996) . Following removal of excess free peptide, the shift in the MI M MII equilibrium toward MII was reduced but still present, indicating that peptide crosslinked to C316 leads to substantial metarhodopsin-II stabilization (Fig. 3A, red) . The presence of two reactive coupling sites, one at each end of the peptide, makes it possible for the peptide to cross link to the reactive cysteine on the cytoplasmic face of rhodopsin in two orientations (Nlinked or C-linked to C316) which leaves the peptide orientation that stabilizes metarhodopsin-II uncertain. If rhodopsin labeling with IA-23S-IA resulted in approximately one peptide crosslinked per rhodopsin molecule as indicated in Fig. 2 , and washing oV uncrosslinked peptide by centrifugation leaves only partial MII stabilization, not all of the crosslinked peptide orientations are capable of shifting the MI M MII equilibrium. Evaluation of the orientation of the peptide crosslink that leads to metarhodopsin-II stabilization was carried out by chemically crosslinking peptides with the N-terminal or the C-terminal residues modiWed with the thiol crosslinking reagents iodoacetate-SE or maleimide-SE. The peptide IA-23S (Table 1 ) was able to stabilize metarhodopsin-II when the peptide is free in solution, as shown by measuring the shift in the MI M MII equilibrium prior to the removal of excess peptide from the crosslinking reaction (Fig. 3B red  circles) . However, following the removal of excess free peptide by centrifugation, the metarhodopsin-II stabilization is absent (Fig. 3B, black squares) . Thus, the peptide chemically crosslinked to C316 by its N-terminus is not capable of stabilizing metarhodopsin-II.
Blocking cysteine 316 with 4,4-dithiodipyridine (DTP) (Albert et al., 1997) initially and then coupling the more reactive maleimide-containing peptide M-23S (Table 1) allowed for selective coupling of peptide M-23S to cysteine 140 on rhodopsin. The extent of modiWcation of cysteine 316 with DTP can be monitored and quantiWed spectrophotometrically. Cysteine 316 on rhodopsin was quantitatively blocked with DTP (data not shown), followed by overnight incubation with peptide M-23S. Covalently linking the amino terminus of M-23S to C140, followed by washing oV excess free peptide and photoactivation led to the stabilization of metarhodopsin-II, as shown by the absorbance diVerence spectra (Fig. 3C) . The extent of peptide mediated metarhodopsin-II stabilization increased following incubation of rhodopsin with increasing amounts of peptide M-23S and washing the unreacted peptide oV the membrane. This eVect was observed comparing the amount of metarhodopsin-II stabilized following incubation of rhodopsin with a threefold molar excess of peptide M-23S (Fig. 3C , dark red squares) compared to incubation of a 30-fold molar excess of peptide (Fig. 3C, red circles) .
Chemical crosslinking of the biotin-containing peptide B-23S-IA (Table 1) to rhodopsin allowed us to biotinaYnity purify and identify the crosslinking site on C316 by mass spectrometry on cleaved peptide fragments. In the absence of an aYnity tag like biotin we were unable to quantitate the extent of peptide crosslinking to sites in rhodopsin, due to diVerences in ionization eYciency of the diVerent CNBr peptide fragments as well as diVerences in ionization eYciency before and after crosslinking. Chemical crosslinking of peptide B23S-IA by the C-terminus to C316 on rhodopsin, followed by washing oV the unreacted free peptide and photoactivation, led to strong metarhodopsin-II stabilization, as evidenced by the increase of the 390-417 nm absorbance diVerence, induced by a series of light Xashes in a light titration series (Fig. 4A) . The amplitude of the light titration response due to metarhodopsin-II stabilization was essentially equivalent to the maximum Fig. 1 . The dark-adapted rhodopsin crystal structure (1U19) (Okada et al., 2004) illustrating the spatial distribution of the residues that have been implicated in mediating the interaction of Gt (340-350) C-terminal tail peptide with metarhodopsin-II (Ernst & Bartl, 2002; Janz & Farrens, 2004; Natochin et al., 2003; Wang et al., 2004) displayed in green in stick format. Cysteine 140 and 316 are rendered as yellow spheres. stabilization that can be obtained (data not shown). The chemical crosslinking of the biotin-containing peptide to C316 was conWrmed by MALDI-TOF mass spectrometry following cleavage of rhodopsin at methionines by CNBr and aYnity enrichment of biotin-containing peptides from the rhodopsin, using streptavidin bound to magnetic beads (Fig. 4B) .
Discussion
Interactions between G protein coupled receptors and the -subunit of the heterotrimeric G proteins have been reported to involve residues on the CII, CIII, and CIV cytoplasmic loops in several diVerent GPCR's (Wess, 1998) . Fig. 3 . Rhodopsin diVerence absorbance spectra showing the shifts in the metarhodopsin-I M metarhodopsin-II equilibrium following chemical crosslinking of Gt C-terminal tail peptide analogs. (A) Peptide IA-23S-IA was incubated with rod outer segments (10 M) at pH 8 at 4°C overnight. Absorbance diVerence spectra were measured for rhodopsin (black squares), rhodopsin with the addition of peptide IA-23S-IA after incubation overnight prior to the removal of excess uncoupled peptide (blue triangles) and following removal of excess uncoupled peptide (red circles). (B) Peptide IA-23S was incubated with rod outer segments (10 M) at pH 8 and 4°C overnight. Absorbance diVerence spectra were measured before (red circles) and after removal of uncrosslinked peptide (black squares). (C) Peptide M-23S threefold molar excess (dark red squares) or 30-fold molar excess (bright red circles) was incubated with rod outer segments (10 M), that had been treated with 4,4Ј-dithiodipyridine to block C316, at pH 8 at 4°C overnight. The absorbance diVerence spectra were measured after removal of uncrosslinked peptide in the curves shown. Fig. 4 . Crosslinking peptide B23S-IA to C316 on rhodopsin leads to the stabilization of metarhodopsin-II. Peptide B23S-IA was incubated with rod outer segments (10 M) at pH 8 at 4°C overnight and uncoupled peptide was removed by centrifugation. (A) Metarhodopsin-II formation following Xash photolysis of rhodopsin in the absence of peptide (black squares) or in the presence of B23S-IA crosslinked to rhodopsin after unreacted peptide was removed (red circles) was monitored for the diVerence in absorbance (390-417 nm). Four hundred and seventeen nanometers is the isosbestic point between MI and MII and 390 nm provides the highest signal to noise for monitoring the levels of MII. Flash photolysis bleached »8% of the total rhodopsin per Xash. (B) MALDI-TOF mass spectrum of a CNBr cleavage product of rhodopsin showing peptide B-23S-IA crosslinked to the rhodopsin peptide containing C316. After coupling to peptide B-23S-IA, washing oV unreacted peptide by centrifugation, and measurement of metarhodopsin-II stabilization-rhodopsin was chemically cleaved with CNBr. Peptide fragments coupled to the biotin-containing B23S-IA were aYnity puriWed using streptavidin-Dyna magnetic beads, detected by MALDI-TOF mass spectrometry and found to be coupled to 310 NKQFRNCh 317 (theoretical mass 2458.50, observed mass 2458.16).
The residues that have been implicated in mediating interactions of the C-terminal peptide of Gt with metarhodopsin-II are illustrated in Fig. 1 . Evidence for the interacting residues illustrated was based primarily on sitespeciWc mutagenesis experiments, which might alter protein interactions by changing protein conformation, rather than revealing direct sites of interactions.
Hydrophobic interactions between rhodopsin and the Cterminal tail of Gt have been proposed. The Cys ¡4 residue of the C-terminal tail of Gt may be involved in a hydrophobic interaction, since substitution with amino butyric acid, where the methylene-sulfhydryl group is replaced with an ethyl group, maintains the activity of the C-terminal peptide, whereas a cysteine to alanine substitution reduces the metarhodopsin-II stabilizing activity of the peptide 3-fold (Aris et al., 2001) . It has been shown that replacing the positive charge contributed by the lysine in the ¡10 position with leucine greatly increases the aYnity of the C-terminal Gt peptide analog (VLEDLKSCGLF, called 23S) for binding and stabilizing metarhodopsin-II (Martin et al., 1996) . The native sequence has a higher oV rate (Angel and Dratz, unpublished) which can support larger G protein ampliWcation by light-excited rhodopsin, but lower aYnity. We have chosen to use the high-aYnity C-terminal Gt peptide analog in these crosslinking studies as the increased aYnity of this peptide presumably will favor speciWc binding.
Interactions between rhodopsin's fourth cytoplasmic (C IV) loop (now known to include helix 8) on the cytoplasmic surface and Gt peptide analogs have been implicated, since replacing 310 NKQ 312 on rhodopsin with the homologous sequence from the 2 adrenergic receptor abolished the capacity of the Gt C-terminal peptide, IRE-NLKCGLF to inhibit rhodopsin photoregeneration (Ernst et al., 2000) . Photocrosslinking, diVerential chemical modiWcation, and mutagenesis studies all indicate the C IV loop (helix 8) is part of the Gt C-terminal peptide binding site (Acharya et al., 1997; Cai et al., 2001; Wang et al., 2004) . Fluorescence-quenching studies place the N-terminus of Gt analogs near C140 during metarhodopsin-II stabilization (Janz & Farrens, 2004) .
Mutagenesis studies suggest that a hydrophobic region on the C III loop of rhodopsin mediates Gt C-terminal peptide analog-receptor interactions (Yang et al., 1996) . Residues 342 ENLK 345 of the C-terminus of Gt have been crosslinked to residue 240 on the CIII loop of rhodopsin, but the crosslinked residue on Gt was not determined ). C140 and S240 are 15 Å apart in the crystal structure of the unactivated receptor. Thus, the crosslinking results of Cai et al., place 342 ENLK 345 of the C-terminal region of the transducin 340-350 tail peptide somewhat near C140 on rhodopsin during transducin-metarhodopsin-II coupling, but do not provide more detailed information regarding the relative orientation of transducin when interacting with activated rhodopsin. The Gt C-terminal tail has been shown to assume an ordered secondary structure when binding to metarhodopsin-II by transferred NOESY NMR experiments (Dratz et al., 1993; Kisselev et al., 1998; Koenig et al., 2000) . The angle of the bound Cterminal Gt peptide, with respect to the average helical axis of metarhodopsin-II was determined to be 40 § 4° ( Koenig, 2002) , however the NMR experiments provided no evidence for the binding sites of the C-terminal Gt peptide on metarhodopsin-II.
When the N-terminus of the Gt peptide analog M-23S (Table 1) was crosslinked to C140, and the excess free peptide was washed oV, substantial metarhodopsin-II stabilization was observed (Fig. 3C) . A dose-response was obtained that increased greatly at the highest peptide concentration tested (Fig. 3C) . Thus, if the amino terminus of synthetic peptide analogs of the Gt C-terminal tail is crosslinked to the C140 residue on the cytoplasmic tip of helix 3 of rhodopsin, this is a suYcient placement of the peptide to shift the metarhodopsin equilibrium to strongly stabilize metarhodopsin-II. The cytoplasmic ends of helix 3 and helix 5 have both been implicated in Gt C-terminal 340-350 peptide binding (Fig. 1) . These helices are not required to move apart for transducin activation as demonstrated with "straight jacketed" mutants with restricted motion due to engineered disulWdes (Struthers, Yu, Kono, & Oprian, 1999; . The crosslinking of peptide M-23S to C140 and the resultant metarhodopsin-II stabilization is consistent with the notion that there is a Gt C-terminal binding site partly composed of the cytoplasmic regions of helix 3 and helix 5.
Crosslinking peptide B23S-IA to C316 by the C-terminus also led to strong metarhodopsin-II stabilization, as shown by light titration experiments (Fig. 4A) . Light titration data can provide information on the ligand binding constant (Parkes et al., 1999) (although binding constant analysis was beyond the scope of the present work). Residues near the 8th helix of rhodopsin have been reported to be involved in interactions with the C-terminal Gt peptide (Ernst et al., 2000) . When peptide IA-23S is crosslinked to C316 by the peptide's N-terminus, metarhodopsin-II is not stabilized (Fig. 3B) , therefore the metarhodopsin-II stabilizing eVects of peptide crosslinks are sensitive to the orientation of the crosslinked peptide on the surface of rhodopsin. The observation in Fig. 3A that free bifunctional IA-23S-IA fully stabilizes MII (blue curve), but washing oV the free peptide leaving the crosslinked peptide (Fig. 2) only partially stabilizes MII (red curve), suggests that if the peptide is crosslinked to C316 by the inactive N-terminal end that the unproductive peptide can swing out of the way and allow a free peptide to bind and stabilize MII.
We have found that chemically crosslinking the C-terminal peptide of Gt at the amino terminal region of C2 loop and at the middle of helix 8 both result in strong MII stabilization, if the peptides are crosslinked in suitable N ! C orientations. Site directed spin labeling studies imply that upon receptor activation helix 7 and helix 3 move away from one another, helix 6 moves away from helix 3 and helix 8, and there is increased mobility and possible structural rearrangement of residue C140 (Hubbell et al., 2003) . A disulWde crosslink between C316 and C65 does not abolish receptor activation of transducin, indicating that CI and helix 8 do not move apart greatly during receptor activation (Cai, Klein-Seetharaman, Hwa, Hubbell, & Khorana, 1999; Struthers, Yu, & Oprian, 2000; Yang et al., 1996) .
The NMR structure of the peptide analog of the C-terminal tail of Gt bound to metarhodopsin-II measures 17 Å end-to-end from amino terminus to the extended side chain of Leu ¡3 in the most reWned bound peptide structure (Koenig, 2002) , whereas the distance between C140 and C316 in dark-adapted rhodopsin is 28 Å. Our Wnding that crosslinking peptides to either C140 or C316 on rhodopsin leading to metarhodopsin-II stabilization was unexpected, given that the conformational changes in the transmembrane helices that are thought to take place during metarhodopsin-II formation would tend to increase the distance between crosslink sites C140 and C316 (Hubbell et al., 2003) , rather than decrease the distance.
How can essentially identical Gt peptide analogs crosslinked by their C-terminus to C316 or by their N-terminus to C140 both lead to metarhodopsin-II stabilization when these regions are 28 Å apart in rhodopsin and the peptide is only 17 Å long when bound to metarhodopsin-II? One way to rationalize these Wndings would be if helix 8 of rhodopsin where to rotate (clockwise) about the axis of helix 7 upon formation of MII, which would decrease the distance between C316 and C140. A movement of helix 8 towards C140 could bring a large fraction of the residues that are reported to be involved in the contact interface for Gt C-terminal tail peptide on rhodopsin much closer together, as can be seen in Fig. 1 . Consistent with a rotation of helix 8, moving C316 closer to C140 upon formation of MII is the Wnding of Yu et al. (1999) that C140 and C316 could not be crosslinked in dark-adapted rhodopsin, but could be crosslinked after light excitation. Such a rotational motion of H8 on the surface of rhodopsin does not seem to be excluded by other measurements (Altenbach, Cai, Klein-Seetharaman, Khorana, & Hubbell, 2001; Yu et al., 1999) and could explain how essentially the same peptide crosslinked to residues that are »28 Å apart in rhodopsin could have similar capacities to stabilize metarhodopsin-II by interacting with similar residues in a more compact pocket on the surface of rhodopsin between C140 and C316.
Alternatively, peptides crosslinked to C316 in productive orientation could be interacting with a largely diVerent set of residues on metarhodopsin-II relative to the interactions of the peptides crosslinked to C140. Metarhodopsin-II has been divided into isospectral species called MIIa or MII ¤ and MIIb or MIIH + (Arnis & Hofmann, 1993; Jager, Szundi, Lewis, Mah, & Kliger, 1998; Szundi et al., 1998) . The transition from MIIa to MIIb involves the uptake of a proton from the bulk solvent mediated by E134 and may involve the opening up of the cytoplasmic face of rhodopsin upon formation of metarhodopsin-IIb (Arnis & Hofmann, 1993; Hofmann, 1999) . Metarhodopsin-II stabilization observed by peptides crosslinked at C140 or C316 could be diVerent isospectral metarhodopsin-II species, which may also be consistent with a previously proposed two site sequential Wt mechanism for G protein activation (Kisselev, Meyer, Heck, Ernst, & Hofmann, 1999) . We speculate that when peptide is crosslinked at C316 via the peptide C-terminus, it might stabilize the more compact MIIa, whereas the peptide crosslinked to C140 via the peptide N-terminus could bind to and stabilize MIIb, which is thought to be the conformation that activates the G protein. Considering the crosslinking results of Cai et al. (2001) , the Xuorescence quenching results of Janz and Farrens (2004) and our chemical crosslinking results together, it is suYcient and it may be necessary for the N-terminus of the C-terminal Gt 340-350 peptide tail of transducin to be near C140 on helix 3, when C-terminal Gt peptides stabilize the active MII conformation of the receptor.
